A high risk of malignant ovarian tumors is observed in women over the age of 49 with a burdened hereditary history (mutations of the BRCA1 and BRCA2 genes, Lynch syndrome, etc.)and after ovarian hyperstimulation, when using hormone replacement therapy, endometriosis, or obesity. The gene discussed is BRCA2; the disease is endometriosis.